<html>
<head>PUBMED IDs for TMEM14C</head>
<body bgcolor='#C5F0F2'><h1>TMEM14C</h1><a href='https://pubmed.ncbi.nlm.nih.gov/25424858/'>SF3B1 mutations constitute a novel therapeutic target in breast cancer.</a> April 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25424851/'>Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.</a> September 24  2014<br></body></html>
